Google introduced on Wednesday that it has obtained FDA clearance for the Pixel Watch 3’s “Loss of Pulse Detection” function and will likely be launching it within the U.S. on the finish of March.
The function can detect when a consumer’s coronary heart stops beating on account of an occasion like major cardiac arrest, respiratory or circulatory failure, overdose, or poisoning. If the watch detects a lack of pulse, it would ask the consumer if they’re okay. If they’re unresponsive, the watch will robotically place a name to emergency companies for doubtlessly life-saving care.
Loss of Pulse Detection first launched within the EU in September 2024, and is at the moment obtainable in 14 nations.
When Google introduced the function ultimately yr’s Made By Google occasion, the corporate famous that the watch determines a lack of pulse occasion by not solely checking a consumer’s pulse, however by additionally different physiological and movement knowledge. It then ties these components collectively through a wise AI-driven algorithm.
Google notes that “Loss of Pulse Detection could not detect each occasion of a lack of pulse and isn’t supposed for customers with preexisting coronary heart situations or those that require cardiac monitoring. It doesn’t diagnose or deal with any medical situation or present follow-up care. Emergency calling relies on name performance corresponding to your telephone or watch being charged and having ample mobile connectivity.”
The new function joins Pixel Watch’s different security and well being options, together with Car Crash Detection, Fall Detection, Irregular Heart Rhythm Notifications, and the ECG app.
